greystone research associates studies the influence of branding and valueadded devices on injectable drugs. in terms of total sector revenue as well as doses, as prefilled injection devices carry on to replace biotech program and vials pharmaceutical, managers are ever more integrating selfinjection device technology and syringe into their development plans. the output has been a migration toward an everincreasing dependence on accelerated product viability testing and multifunctional development teams. as the aspects driving this tendency continue to develop over the span of next six years, the quantity of tailored injectable drug products that introduced in the market will go up. as a utilitarian and elegant type of injectable drug packaging, prefilled syringes symbolize a milestone success story of the convergence of market requirements and device engineering. prefilled syringes are still experiencing doubledigit yearly unit growth a little more twelve percent in 2011. not unpredictably, development in prefilled syringe tool technology and design has resulted to the rising accessibility of devices that offer incremental worth to drug marketers with product precincts that afford these higher cost devices. efficient delivery of highpriced biologicals, improved patient compliance, and caregiver & patient safety are key market drivers in this field. the price of biologicals like recombinant proteins has generated interest in prefilled syringes to lessen cost and waste related to the handling of vialpackaged drugs. in the success of prefilled devices, partnerships between drug developers and device designers are an important element, specifically for patient selfadministration. a comprehensive report on universal prefilled syringe markets that was conducted by greystone research associates has just been published. the name of the report is &lsquoprefilled syringes to 2018 devices, drugs, markets, players and prospects&rsquo. this report includes assessments and analysis of injectable drugs, prefilled syringe devices, and combination products, assessments of therapeutic markets, profiles of market participants, and an inspection of market factors. source of information httpwww.scoop.co.nzstoriesge1302s00080productstrategiesforprefilledsyringes…
